Michael Carter

Venture Partner

Michael joined SV as a Venture Partner in 1998.

Prior experience
Before joining SV, from 1986 to 1998 Michael served on the board of ICI/Zeneca Pharmaceuticals. From 1995 to 1998, he was also a board member of Salick Healthcare, a US subsidiary of Zeneca. He was International Marketing Director at ICI/Zeneca Pharmaceuticals; in addition, as ICI/Zeneca’s International Medical Director, he was involved in the clinical and commercial development of over 20 new medicines. For 10 years, from 1986 to 1996, he was a member of the UK Government’s Medicines Commission. He has also worked at Roche Products as Director of the Pharmaceutical Division. He served on the boards of CancerVax, Genosis, Fulcrum, KuDOS, Micromet, Oncoethix, Santarus Inc. and Warner Chilcott / Galen.


Before entering the pharmaceutical industry, Michael practiced as a physician for 11 years.

Academic credentials
BPharm (Hons), London University School of Pharmacy; MB.CHB., Sheffield University Medical School

Outside of SV
Michael is an elected Fellow of the Royal Pharmaceutical Society, the Royal College of Physicians of Edinburgh, and the Faculty of Pharmaceutical Medicine of the Royal College of Physicians. He currently serves on the board of GTx Inc, and is a member of the Strategic Advisory Board and Investment Committee of Healthcare Royalty Partners.

Venture Partners


Sector Administrator
Natalie Ellengold


Current Portfolio

Past Portfolio

EUSA Pharma, Inc.
Genosis plc
KuDOS Pharmaceuticals Limited
Metris Therapeutics Limited
Micromet, Inc. (Fund I)
Micromet, Inc. (Fund IV)
Oncoethix SA